The Alkaline Water Company Partners with Water Source One
January 18, 2019
Ryan Allway January 18th, 2019 News, Top News Agreement Expands Production and Distribution Capabilities SCOTTSDALE, Ariz., Jan. 18, 2019 (GLOBE NEWSWIRE) — The Alkaline Water Company Inc. (NASDAQ and TSXV: WTER)(the “Company”), a leading producer of premium bottled alkaline drinking water sold under the brand name Alkaline88®, today announced it has... Read more
Aleafia Health Completes Strategic Investment in Australia’s CannaPacific Pty Limited
January 18, 2019
Ryan Allway January 18th, 2019 News, Top News Global Expansion Underway with 10% Equity Investment in Licensed Cannabis Cultivator CannaPacific among Australia’s only Federally Licensed Cultivators with projected 108,000 sq. ft. Greenhouse More TORONTO, Jan. 18, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSXV: ALEF: OTCQX: ALEAF, FRA: ARAH)... Read more
Ryan Allway January 16th, 2019 Uncategorized The cannabis industry experienced significant growth last year, particularly in Canada following the legalization of adult-use cannabis on a federal level. The upcoming legalization of edible products across Canada could open the door to further growth in 2019 and beyond. Health Canada also... Read more
Yield Growth Announces 9 new products, pass stability testing
December 27, 2018
Ryan Allway December 27th, 2018 News, Top News VANCOUVER, British Columbia, Dec. 27, 2018 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS) announces that the following 9 new products have completed stability and preservative challenge tests in accordance Health Canada regulations: Sunscreen Pain balm Sports spray Topical analgesic... Read more
Pascal Biosciences Provides Year-End Investor Update and Reviews Upcoming Milestones
December 20, 2018
Ryan Allway December 20th, 2018 – 2018 pipeline expansion includes lead cannabinoid-based cancer therapeutic– Clinical trial in glioblastoma to begin in 2019 VANCOUVER, British Columbia and SEATTLE, Dec. 20, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced... Read more
Creso Pharma Brings Together Cannabis Experts Across Several Verticals
December 18, 2018
Ryan Allway December 18th, 2018 Exclusive, Top News The due diligence process looks very different for small-cap versus large-cap stocks. When analyzing large-cap companies, investors pay closest attention to financial statements and valuation ratios to extrapolate growth rates and apply multiples. Small-cap stocks tend to be earlier stage... Read more
Ryan Allway November 28th, 2018 Uncategorized The global cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, representing a blistering 34.6 percent compound annual growth rate. With medical and adult-use legalization across a growing number of countries, there’s an enormous opportunity for... Read more
MedMen Expanding Across the US Legal Cannabis Markets
November 15, 2018
Ryan Allway November 15th, 2018 Exclusive, News, Top Story The recent elections brought the total number of states allowing some form of legalized cannabis to 33, with Michigan expanding its medical program to full adult use legalization and both Utah and Missouri voting for regulated medical programs. The... Read more
Ryan Allway November 8th, 2018 Exclusive, News, Press Releases, Top News In late October of this 2018, 48North Cannabis Corp. (TSX-V: NRTH) entered into a binding letter agreement to acquire all issued and outstanding common shares of privately-held Good & Green, a socially-responsible, organic cannabis brand. Combined with... Read more
Pascal Biosciences Announces Optimization of Cannabinoid-Derived Drug Candidates to Kill Glioblastoma Cells
November 5, 2018
Ryan Allway November 5th, 2018 News, Press Releases VANCOUVER, British Columbia and SEATTLE, Nov. 05, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the peer reviewed publication and upcoming presentation of their recently licensed cannabinoid-derived drug... Read more
